Genetic Engineering and Biotechnology News

NANOPARTICLE-BASED DRUG DELIVERY AND THERAPY

– GEN’s Editor-in-Chief John Sterling interviews Alan Crane, CEO, Tempo Pharmaceuticals

PodcastsResourcesCancersCombination drug therapyDrug deliveryDrug therapyMedicine, Diagnosis, and TherapeuticsNanoparticlesNanotechnologyPharmacokineticsPharmacologySystemic conditionsTechnology and Computational BiologyTherapeuticsTumorsMillennium Pharmaceuticals
Also of Interest
Watching Cancer Proteins in Real Time, with Help from Rare Earth Elements
FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
How Cells Respond Differently to a Cancer-Causing Gene
New Liposome Design Could Provide Effective Slow-Release Drug Delivery System
Basecamp Research Raise $140M Series C Financing Toward Advancing AI-Designed Drugs
Related Media
AACR 2026: A Video Update from San Diego
AI in Protein Design: Hype vs. Reality Explained by David Baker
AACR 2025: A Video Update from Chicago
Avak Kahvejian, PhD, Recounts His Journey from Sequencing Pioneer to Flagship General Partner on "Close to the Edge"
AACR 2024: A Video Update from San Diego
Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning